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Integrating community pharmacy and
NHS Direct — pharmacists’ views
By Emma Knowles, MA, James Munro, MRCP, MFPHM,
Alicia O’Cathain, MSc, and Jon Nicholl, MSc, FFPHM
AIM • To establish the views of community pharmacists
on NHS Direct and its forthcoming integration with
community pharmacy.
DESIGN • Postal questionnaire survey.
SUBJECTS AND SETTING • Pharmacists working in
community pharmacies within the area of the NHS
Direct pharmacy pilot scheme — Essex, Barking and
Havering.
RESULTS • The response rate to the postal survey was
72% (263/364). Most pharmacists were generally sup-
portive of NHS Direct (80%) and the pharmacy scheme
in principle (83%), although their experience of the
scheme in practice was limited. Perhaps because of this,
the majority of pharmacists were unsure as to whether
NHS Direct was referring appropriately, or whether the
pharmacy would be able to meet the needs of patients
without further referral. Almost half believed that
patients referred by NHS Direct should be seen in a qui-
et area, away from the counter. Over two-thirds of phar-
macists were willing to accommodate an NHS Direct
information point in their pharmacy, although space was
an issue.
CONCLUSION • Overall, the results of this study sug-
gest that community pharmacists welcome their
increasing involvement in the developing immediate
care system. As the Government commitment in the
NHS plan to integrate community pharmacy with NHS
Direct becomes a reality across England and Wales over
coming months the implications for pharmacists, in
terms of workload and the adequacy of premises, will
become clearer. Careful audit of the operation of the
scheme will be essential.
R
ecent developments in the
National Health Service — in
particular, the arrival of NHS
Direct and walk-in centres, and
the current reorganisation of primary care
— seem to be leading towards the creation
of an integrated system of “immediate care”
in which patients are quickly directed to the
health professional most able to meet their
needs.1 NHS Direct is a 24-hour telephone
advice line staffed by nurses which was
established to offer “easier and faster advice
and information for people about health, ill-
ness and the National Health Service so that
they are better able to care for themselves
and their families”.2 Three pilot sites were
established in England in 1998 with the
whole population of England and Wales
covered by 2001. A Scottish version, NHS
24, will begin operating in mid 2002.
Although the role of community phar-
macists in such a system was initially slow to
emerge, there is now a wide-ranging and
rapidly developing agenda for change which
recognises the many contributions which
pharmacists can make.3,4 Notably, however,
the initial implementation of NHS Direct in
England and Wales did not envisage any
particular role for community pharmacists.5
Until now, the standard approach of the
NHS Direct telephone service has been to
offer callers self-care advice, to advise them
to contact their general practitioner or local
accident and emergency department, or in
urgent cases to divert their call to the emer-
gency ambulance service. However, the
Government made a commitment in the
NHS plan that, by 2002, “NHS Direct will
refer people, where appropriate, to help
from their local pharmacy”6 and followed
this with the appointment of pharmacists to
advise Department of Health teams on
NHS Direct and walk-in centres.7
Other roles for pharmacists in the
immediate care system are also developing.
As well as taking referrals from NHS Direct,
pharmacists may become involved in han-
dling the medicines enquiries of NHS
Direct callers on the telephone.8 In addi-
tion, the NHS plan has promised that by
2004 more than 500 NHS Direct informa-
tion points giving touch-screen information
and advice about health will be available,
some of which will be located in community
pharmacies.6
A scheme to pilot the referral of patients
from NHS Direct to community pharma-
cists was established in Essex in March 2000,
with the aims of further integrating NHS
Direct with other immediate care services
—  in this case pharmacy — while appropri-
ately, safely and conveniently meeting the
needs of callers. Previous research into how
and why patients choose to seek advice from
pharmacists suggested that this develop-
ment might prove both acceptable and help-
ful to patients.9–12
We evaluated of the scheme to deter-
mine its impact on callers, pharmacists and
the wider NHS. Here, we report the results
of our study, which assessed the views and
experiences of community pharmacists
within the area covered by the scheme.
METHOD
We carried out a postal questionnaire of one
pharmacist in each community pharmacy
covered by the scheme in September 2000,
approximately six months after the start of
the pilot scheme. The addresses of commu-
nity pharmacies were obtained from the
local pharmaceutical committee registers in
Essex, Barking and Havering; 365 pharma-
cies were provided. Up to two reminders
were sent to non-responders.
It became clear as the survey was being
developed that the number of referrals by
NHS Direct to pharmacists was lower than
expected, so that any one pharmacist’s direct
experience of the scheme was likely to be lim-
ited. In view of this, we focused a number of
questions on impressions, rather than experi-
ence, of the scheme so that respondents
would have the opportunity to offer their
opinions without necessarily having had
direct experience of dealing with an NHS
Direct referral. The final survey included
questions on general impressions of NHS
Direct, impressions of the pharmacy pilot
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scheme, experience of the scheme, views on
NHS Direct information points, and ques-
tions about the respondent and the pharmacy.
Survey data were entered into Microsoft
Access and exported into the Statistical
Package for the Social Sciences (SPSS) for
analysis. The study was approved by the
local research ethics committees.
RESULTS
Response rates Of the 365 questionnaires
mailed, one questionnaire was returned by
the Royal Mail. In all, 263 usable responses
were returned, giving a response rate of 72
per cent (263/364).
Characteristics of respondents Of the
respondents, 67 per cent (174/260) were
male, 40 per cent (105/261) owned their
pharmacy, and 57 per cent (147/259) of
pharmacies were located in a suburban area.
Of pharmacies, 46 per cent (121/262) were
independent, 39 per cent (103/262) were
part of a national chain and 15 per cent
(38/262) were part of a local chain. Respon-
dents had been on the Register of Pharma-
ceutical Chemists for a mean time of 16
years.
Experience of NHS Direct Pharmacists had
little experience of using NHS Direct them-
selves. Only 10 per cent (26/259) of respon-
dents had ever contacted NHS Direct as a
user, whether on behalf of themselves or
someone else.
Experience of receiving referrals from
NHS Direct through the pilot scheme was
also low. Of pharmacies, 35 per cent
(90/259) were aware of having dealt with an
NHS Direct referral in the six months since
the scheme began. Of these, 59 pharmacists
(22 per cent of all respondents) reported
dealing with one or more referrals in the
previous month, amounting to 161 patients
in total.
Views of NHS Direct Pharmacists were
asked for their views on NHS Direct (Table
1). Overall, respondents appeared to be pos-
itive about the service. High levels of agree-
ment with general statements about the
value of NHS Direct to patients and to the
NHS indicated strong support for NHS
Direct in principle. However, more specific
statements about the “value for money” of
NHS Direct and its impact on the NHS met
with a mixed pattern of responses suggest-
ing less certainty on these issues.
Views of the scheme before it began We
asked respondents to think about the views
they held of the pilot scheme before it start-
ed. Three-quarters (194/263) said that they
had been supportive of plans for the scheme,
even though half (130/262) had expected it
to lead to an increase in workload.
Views of the scheme in operation Respon-
dents were asked for their impressions of the
pharmacy scheme in operation (Table 2).
Overall, the responses indicated a high level
of support for the scheme in principle
regardless of whether or not pharmacists
had direct experience of the scheme, and
suggested that there was good understand-
ing of how the scheme worked.
However, as might be expected in the
absence of much experience of the scheme,
there was considerable uncertainty about
how well the scheme operated in practice, in
terms of whether patients were appropriate-
ly referred to pharmacists. Encouragingly,
those pharmacists who did have experience
of an NHS Direct referral were significantly
more likely to feel that they had a good
understanding of the scheme (84 per cent
versus 68 per cent, c2=8.587, P<0.02), and
that referrals through it were appropriate
(42 per cent versus 19 per cent, c2=16.708,
P<0.001), than those who had no experi-
ence. 
We asked about a number of other prac-
tical issues for pharmacists which might be
raised by dealing with referrals from NHS
Direct. Although about three-quarters of
respondents felt that NHS Direct referrals
merited the personal attention of the phar-
macist, there was a strong rejection of the
idea that patients referred by NHS Direct
should have a higher priority for attention
than other patients of the pharmacy. There
was much less unanimity on the issue of
whether the consultation should be in a qui-
et area, although almost half of pharmacists
believed this was desirable. Experience of
the scheme seemed to make no significant
difference to these views.
Workload Although a half of all respondents
had expected an increase in their workload
before the scheme began, only 6 per cent
(5/90) of those who were aware of seeing a
referral said they had experienced an
increase in workload as a result of the
scheme.
Perceptions of NHS Direct patients A total
of 6 per cent (5/89) of pharmacists did not
feel comfortable about advising patients
referred by NHS Direct. Some 77 per cent
(69/90) reported that patients appeared to
be happy about being referred to the phar-
macy and 86 per cent (77/90) believed that
people accepted the advice given to them by
the pharmacist.
NHS Direct information points Respon-
dents were also asked for their views about
NHS Direct information points and the fea-
sibility of accommodating one in their phar-
macy (Table 3). About a third of pharmacists
were not willing or able to accommodate an
information point, with lack of space given
as the main obstacle. Of those who would
not accommodate an information point,
about one in four believed that information
points should not replace advice from a
pharmacist.
DISCUSSION
Overall, the results of this study suggest that
community pharmacists welcome their
increasing involvement in the developing
immediate care system. Respondents to our
survey were generally supportive of NHS
Direct and of the scheme before it began,
even though there was recognition that it
might lead to an increase in workload, and
they remained positive about the scheme
during its first six months. The high response
rate to our survey gives reason to be confi-
dent that these results accurately reflect the
views of community pharmacists in Essex.
There is no particular reason to believe that
views elsewhere would differ from these. 
Because the number of referrals to phar-
macists through the pilot scheme was lower
Statement Agree/ Not sure Disagree/
strongly agree strongly disagree
I am generally supportive of NHS Direct (n=262) 80% 12% 8% 
NHS Direct is beneficial for patients (n=262) 77% 16% 6% 
NHS Direct is beneficial for the NHS (n=260) 65% 25% 10%
NHS Direct is value for money (n=261) 21% 54% 25%
NHS Direct is an unnecessary addition to
the NHS (n=261) 18% 21% 61%
NHS Direct will increase demands on the
NHS (n=259) 30% 33% 37%
Statement Agree/ Not sure Disagree/
strongly agree strongly disagree
The pharmacy scheme is a good thing for
callers (n=260) 83% 15% 2%
I believe I have a good understanding of how the
NHS Direct pharmacy scheme works (n=261) 73% 18% 9%
Too many NHS Direct referrals have to be sent
on to other services (n=261) 24% 60% 16%
Some NHS Direct callers are inappropriately
referred to pharmacists (n=259) 16% 58% 27%
A pharmacist, rather than a counter assistant,
should deal with people referred by NHS
Direct (n=262) 73% 7% 20%
Pharmacists should spend more time with people
referred by NHS Direct than with other
patients (n=261) 11% 10% 79%
People referred by NHS Direct need a consultation
in a quiet area away from the counter (n=261) 47% 25% 29%
TABLE 1: PHARMACISTS’ VIEWS OF NHS DIRECT
TABLE 2: PHARMACISTS’ IMPRESSIONS OF THE PHARMACY SCHEME
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than had been expected by NHS Direct,
experience among our respondents of deal-
ing with a referral was limited (although
some may have seen patients referred by
NHS Direct without realising it) and our
results should be seen in that light. Not sur-
prisingly, therefore, most pharmacists were
unsure as to whether NHS Direct was refer-
ring appropriately, or whether the pharmacy
was able to meet the needs of patients with-
out further referral onwards.
The issue of whether referrals from
NHS Direct are appropriate has, of course,
View on information points No Percentage
Willing and able to accommodate an information point 86/239 36%
Willing and able if certain conditions were met 84/239 35%
Would not be willing or able to accommodate an information point 69/239 29%
Of those willing and able if certain conditions were met:
if they had more space 44/84 52%
if a financial incentive were offered 24/84 29%
Of those not willing or able to accommodate an information point:
lack of space in pharmacy 46/69 66%
pharmacist rather than computer should advise patients 19/69 27%
financial resource issues 2/69 3%
TABLE 3: PHARMACISTS’ VIEWS ON NHS DIRECT INFORMATION POINTS
been a common concern among health pro-
fessionals.13 Among pharmacists with expe-
rience of a referral, uncertainty over
appropriateness was somewhat lower but
still common, suggesting that a longer peri-
od of “bedding down” will be necessary
before pharmacists are able to form a clear
picture of whether the service is operating
optimally. Local audits of referral to phar-
macy will be needed to ensure the scheme
works well, and community pharmacists
should see themselves as active partners
with NHS Direct in initiating local audit
activity.
The introduction of
the scheme also raises a
number of practical
issues about how
patients referred by
NHS Direct should be
dealt with. A clear
majority of respondents
in this study believed
that referrals should
always be seen by a
pharmacist, but should
not automatically be
given more attention
than other patients of
the pharmacy. In addi-
tion, almost a half
believed that patients
referred by NHS Direct
should be seen in a quiet
area, away from the
counter. Given the lack
of space available for
private consultation in many pharmacies,
however, this may prove to be problematic
and may lead to a lack of compliance with
the referral if the patient believes that priva-
cy is necessary but sees that it is not avail-
able.14
Lack of space also emerged as the cen-
tral concern in considering whether an
NHS Direct information point might be
located in the pharmacy. New funds have
recently been announced in Scotland to
modernise pharmacy premises, which may
include the addition of private consultation
rooms, but no similar announcement has yet
been made in England and Wales.8
Although community pharmacists
report a heavy workload15 and recognise
that referrals from NHS Direct may add to
this, this did not seem to raise any difficul-
ties during this pilot scheme. Of course, as
the commitment in the NHS plan to inte-
grate community pharmacy with NHS
Direct becomes a reality across England and
Wales over the coming months, the work-
load implication for pharmacists is likely to
become more apparent and this situation
may change.
In addition, an increasing volume of
referrals from NHS Direct will inevitably
cause some pharmacists difficulty in balanc-
ing this new demand with that of existing
clients, and the issue of the lack of quiet con-
sultation areas in many pharmacies is also
likely to become pressing. None the less,
our results suggest that, at least at present,
community pharmacists are ready to
embrace their new role in the immediate
care system.
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SPECIAL INTEREST GROUPS
The Royal Pharmaceutical Society has established special interest
groups for community pharmacists, for veterinary pharmacists, for
industrial and technical pharmacists, for hospital pharmacists and
for pharmacy academic staff. 
The groups hold meetings to consider topics of interest within
their own fields of practice and they provide a source of advice to
the Society’s Council on specialist matters. Each group is adminis-
tered by a committee, most of whose members are elected by the
group, the remainder being members of the Council.
Details of the groups can be obtained from the following per-
sons at the Society’s headquarters: Angela Canning (practice divi-
sion) for the Community Pharmacists Group and Industrial
Pharmacists Group (tel 020 7572 2412); Liz Griffiths (practice
division) for the Veterinary Pharmacists Group and Hospital
Pharmacists Group (tel 020 7572 2408); Rachel Ollerearnshaw
(education division) for the Academic Pharmacy Group (020 7572
2375). Written enquiries should be addressed to the Royal Phar-
maceutical Society, 1 Lambeth High Street, London SE1 7JN.
